Literature DB >> 29883322

Marginal Structural Models with Counterfactual Effect Modifiers.

Wenjing Zheng1,2, Zhehui Luo3, Mark J van der Laan1,2.   

Abstract

In health and social sciences, research questions often involve systematic assessment of the modification of treatment causal effect by patient characteristics. In longitudinal settings, time-varying or post-intervention effect modifiers are also of interest. In this work, we investigate the robust and efficient estimation of the Counterfactual-History-Adjusted Marginal Structural Model (van der Laan MJ, Petersen M. Statistical learning of origin-specific statically optimal individualized treatment rules. Int J Biostat. 2007;3), which models the conditional intervention-specific mean outcome given a counterfactual modifier history in an ideal experiment. We establish the semiparametric efficiency theory for these models, and present a substitution-based, semiparametric efficient and doubly robust estimator using the targeted maximum likelihood estimation methodology (TMLE, e.g. van der Laan MJ, Rubin DB. Targeted maximum likelihood learning. Int J Biostat. 2006;2, van der Laan MJ, Rose S. Targeted learning: causal inference for observational and experimental data, 1st ed. Springer Series in Statistics. Springer, 2011). To facilitate implementation in applications where the effect modifier is high dimensional, our third contribution is a projected influence function (and the corresponding projected TMLE estimator), which retains most of the robustness of its efficient peer and can be easily implemented in applications where the use of the efficient influence function becomes taxing. We compare the projected TMLE estimator with an Inverse Probability of Treatment Weighted estimator (e.g. Robins JM. Marginal structural models. In: Proceedings of the American Statistical Association. Section on Bayesian Statistical Science, 1-10. 1997a, Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. EPIDEMIOLOGY: 2000;11:561-570), and a non-targeted G-computation estimator (Robins JM. A new approach to causal inference in mortality studies with sustained exposure periods - application to control of the healthy worker survivor effect. Math Modell. 1986;7:1393-1512.). The comparative performance of these estimators is assessed in a simulation study. The use of the projected TMLE estimator is illustrated in a secondary data analysis for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial where effect modifiers are subject to missing at random.

Entities:  

Keywords:  causal inference; effect modification; epidemiology; machine learning

Mesh:

Year:  2018        PMID: 29883322      PMCID: PMC6682415          DOI: 10.1515/ijb-2018-0039

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   1.829


  9 in total

1.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

Authors:  M A Hernán; B Brumback; J M Robins
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

3.  Doubly robust estimation in missing data and causal inference models.

Authors:  Heejung Bang; James M Robins
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

4.  Super learner.

Authors:  Mark J van der Laan; Eric C Polley; Alan E Hubbard
Journal:  Stat Appl Genet Mol Biol       Date:  2007-09-16

5.  History-adjusted marginal structural models for estimating time-varying effect modification.

Authors:  Maya L Petersen; Steven G Deeks; Jeffrey N Martin; Mark J van der Laan
Journal:  Am J Epidemiol       Date:  2007-09-17       Impact factor: 4.897

6.  Statistical learning of origin-specific statically optimal individualized treatment rules.

Authors:  Mark J van der Laan; Maya L Petersen
Journal:  Int J Biostat       Date:  2007       Impact factor: 0.968

7.  Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.

Authors:  Iván Díaz; Mark J van der Laan
Journal:  Stat Med       Date:  2017-07-25       Impact factor: 2.373

8.  Individualized treatment rules: generating candidate clinical trials.

Authors:  Maya L Petersen; Steven G Deeks; Mark J van der Laan
Journal:  Stat Med       Date:  2007-11-10       Impact factor: 2.373

9.  Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data.

Authors:  Alan R Ellis; Stacie B Dusetzina; Richard A Hansen; Bradley N Gaynes; Joel F Farley; Til Stürmer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-12-28       Impact factor: 2.890

  9 in total
  1 in total

Review 1.  Introduction to clinical research based on modern epidemiology.

Authors:  Junichi Hoshino
Journal:  Clin Exp Nephrol       Date:  2020-03-24       Impact factor: 2.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.